Skip to main content

Table 1 Comparison of baseline data in patients with acute ischemic stroke admitted within 72 h

From: Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes

 

END (n = 661)

Non-END (n = 3153)

P

Age

65.3 ± 12.6

63.5 ± 13.5

0.001

Male sex

409 (61.9%)

2017 (64.0%)

0.309

Hypertension

462 (70.0%)

2052 (65.8%)

0.039

Diabetes mellitus

262 (39.6%)

1098 (34.8%)

0.019

Initial NIHSS

8.2 ± 6.7

5.6 ± 6.3

<0.001

Discharge NIHSS

10.5 ± 10.3

3.2 ± 5.4

<0.001

TOAST

  

<0.001

 Cardioembolism

160 (24.2%)

718 (22.8%)

 

 Atherosclerosis

201 (30.4%)

818 (25.9%)

 

 Small artery disease

159 (24.1%)

614 (19.5%)

 

 Others

141 (21.3%)

1003 (31.8%)

 

Fasting glucose (mg/dL)

151 ± 66

144 ± 63

0.005

Glycated hemoglobin (%)

6.65 ± 1.57

6.46 ± 1.36

0.051

Urine protein positivity

100/441 (22.7%)

276/1896 (14.6%)

<0.001

Fibrinogen (mg/dL)

367 ± 156

347 ± 122

0.002

ESR (mm)

18.15 ± 17.09

17.57 ± 17.01

0.439

CRP (mg/dL)

0.81 ± 2.00

0.73 ± 2.33

0.459

BMI

23.8 ± 3.2

24.0 ± 3.4

0.163

Metabolic syndrome

288 (43.6%)

1295 (41.1%)

0.236

Lipid panel

   

 T.chol (mg/dL)

179.54 ± 42.07

179.15 ± 51.46

0.857

 LDL (mg/dL)

107.42 ± 37.48

105.68 ± 35.45

0.262

 HDL (mg/dL)

45.65 ± 12.87

45.94 ± 13.40

0.616

 TG (mg/dL)

139.77 ± 122.26

142.83 ± 117.81

0.552

  1. END early neurological deterioration, NIHSS National Institutes of Health Stroke Scale, TOAST trial of Org 10,172 in acute stroke treatment, ESR erythrocyte sedimentation rate, CRP c-reactive protein, BMI body mass index, T.chol total cholesterol, LDL low density lipoprotein, HDL high density lipoprotein, TG triglyceride
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us